Claudio Dansky Ullmann, Linda C. Harlan, Vickie L. Shavers and Jennifer L. Stevens A population-based study of therapy and survival for patients with head and neck cancer treated in the community Cancer 118
Article first published online: 17 JAN 2012 | DOI: 10.1002/cncr.27419
Findings in particular tumor sites and stages may reflect the variability that still exists for the treatment of head and neck cancer. The use of taxanes and cetuximab will continue to increase based on new evidence of benefit.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.